GE HealthCare said that in the second quarter of Q2 2026, it combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions (AIS), resulting in three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).

8-KRegulation FD DisclosureFiled Jul 29, 2026Period of report Jul 29, 2026Summary published (UTC) Oct 7, 2026

Key points

AI summary

GE HealthCare said that in the second quarter of Q2 2026, it combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions (AIS), resulting in three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).
The company said Exhibit 99 presents recast unaudited historical financial information reflecting the new segment structure and is being provided to aid in comparability, with no impact on previously reported financial statements.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call. Some paragraphs were omitted because their support in the source could not be confirmed.

New AIS segment combining Imaging and AVS

GE HealthCare said that in the second quarter of Q2 2026, it combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment, Advanced Imaging Solutions (AIS), resulting in three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).

Source · Based on the filing body and exhibits

Recast information is unaudited historical financial data for comparability

The company said Exhibit 99 presents recast unaudited historical financial information reflecting the new segment structure and is being provided to aid in comparability, with no impact on previously reported financial statements.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.